Medication info
H2B Tablet 200 mg (Cimetidine)

H2B Tablet 200 mg (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
1000 tablets/bottle
Approval status
Active

MFDS item code 201403952 · Approved 2014.08.25 · Insurance code 644102510

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease); improvement of gastric mucosal lesions in gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medication twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medication may accumulate in the body; therefore, minimize the frequency of administration according to the patient's response. Hemodialysis lowers the cimetidine concentration in the blood. After hemodialysis is completed, administer the medication again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease); improvement of gastric mucosal lesions in gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for the treatment of diseases such as ulcers of the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers after surgery, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling that occur during acute exacerbation of acute gastritis and chronic gastritis. Therefore, this drug is effective in alleviating and treating the symptoms of various gastrointestinal disorders.

How to take

Adult dose

Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medication twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medication may accumulate in the body; therefore, minimize the frequency of administration according to the patient's response. Hemodialysis lowers the cimetidine concentration in the blood. After hemodialysis is completed, administer the medication again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

If this drug is in injectable form, care should be taken to prevent glass fragments from mixing in when cutting the glass container. Extra caution is necessary, especially when used by children or the elderly. People who have had allergies or hypersensitivity reactions to the ingredients in this medication should not take it. It may be dangerous to use this drug together with certain heart arrhythmia treatments, so those should not be used concomitantly. Patients with weak kidney or liver function, the elderly, children under 19 years old, and those undergoing dialysis need dose and interval adjustments when taking this medication. This drug can mask symptoms of gastric cancer, therefore it should be administered only after ruling out gastric cancer. In patients with gastric and duodenal ulcers who test positive for Helicobacter pylori, eradication therapy should be undertaken simultaneously. This drug may cause various side effects such as a decrease in blood cell counts, liver function abnormalities, kidney problems, allergic reactions, endocrine abnormalities, digestive disorders, nervous system issues, cardiac rhythm disturbances, and severe skin reactions. If such symptoms occur, use should be discontinued immediately and medical attention should be sought. During treatment, the course of the illness should be closely monitored, only the minimum effective dose should be used, and if ineffective, alternative treatments should be considered. Particularly in the elderly or those with chronic conditions, there may be an increased risk of pneumonia that should be cautiously monitored. When used with other medications, there can be numerous interactions that may alter serum drug concentrations, therefore dose adjustments should be discussed with a physician or pharmacist. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this drug, and it is advisable to discontinue breastfeeding while taking it. The safety of this drug in pediatric populations has not been fully established, therefore it should only be used when absolutely necessary. The elderly may experience increased drug concentrations due to decreased kidney function, requiring dose reductions or extending intervals. In case of overdose, there is a risk of respiratory depression and emergency treatment should be sought immediately, and injection should be administered slowly to reduce the risk of side effects. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • generalized fatigue
  • weakness
  • subcutaneous hemorrhage
  • subconjunctival hemorrhage
Show 50 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusion
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • systemic warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is important to maintain storage temperatures between 1 degrees and 30 degrees Celsius.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.